Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders.

Dedeić Z, Sutendra G, Hu Y, Chung K, Slee EA, White MJ, Zhou FY, Goldin RD, Ferguson DJP, McAndrew D, Schneider JE, Lu X.

Cell Death Differ. 2018 Jul;25(7):1289-1303. doi: 10.1038/s41418-017-0039-6. Epub 2018 Jan 19.

2.

ASPP2 deficiency causes features of 1q41q42 microdeletion syndrome.

Zak J, Vives V, Szumska D, Vernet A, Schneider JE, Miller P, Slee EA, Joss S, Lacassie Y, Chen E, Escobar LF, Tucker M, Aylsworth AS, Dubbs HA, Collins AT, Andrieux J, Dieux-Coeslier A, Haberlandt E, Kotzot D, Scott DA, Parker MJ, Zakaria Z, Choy YS, Wieczorek D, Innes AM, Jun KR, Zinner S, Prin F, Lygate CA, Pretorius P, Rosenfeld JA, Mohun TJ, Lu X.

Cell Death Differ. 2016 Dec;23(12):1973-1984. doi: 10.1038/cdd.2016.76. Epub 2016 Jul 22.

3.

Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.

Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeić Z, Slee EA, Baer C, Lu X.

Oncotarget. 2015 Dec 15;6(40):42478-90. doi: 10.18632/oncotarget.6478.

4.

Requirement for phosphorylation of P53 at Ser312 in suppression of chemical carcinogenesis.

Slee EA, Lu X.

Sci Rep. 2013 Oct 31;3:3105. doi: 10.1038/srep03105.

5.

In the right place at the right time: analysis of p53 serine 312 phosphorylation in vivo.

Slee EA, Lu X.

Cell Cycle. 2011 May 1;10(9):1345-6. Epub 2011 May 1. No abstract available.

PMID:
21445010
6.

Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo.

Slee EA, Benassi B, Goldin R, Zhong S, Ratnayaka I, Blandino G, Lu X.

Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19479-84. doi: 10.1073/pnas.1005165107. Epub 2010 Oct 20.

7.

Regulation of caspase activation in apoptosis: implications for transformation and drug resistance.

Slee EA, Martin SJ.

Cytotechnology. 1998 Sep;27(1-3):309-20. doi: 10.1023/A:1008014215581.

8.

A complex barcode underlies the heterogeneous response of p53 to stress.

Murray-Zmijewski F, Slee EA, Lu X.

Nat Rev Mol Cell Biol. 2008 Sep;9(9):702-12. doi: 10.1038/nrm2451. Review.

PMID:
18719709
9.

ASPP2: a gene that controls life and death in vivo.

Vives V, Slee EA, Lu X.

Cell Cycle. 2006 Oct;5(19):2187-90. Epub 2006 Oct 1. Review.

PMID:
16969108
10.

The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization.

Slee EA, Gillotin S, Bergamaschi D, Royer C, Llanos S, Ali S, Jin B, Trigiante G, Lu X.

Oncogene. 2004 Dec 2;23(56):9007-16.

PMID:
15489900
11.

To die or not to die: how does p53 decide?

Slee EA, O'Connor DJ, Lu X.

Oncogene. 2004 Apr 12;23(16):2809-18. Review.

PMID:
15077144
12.

The ASPP family: deciding between life and death after DNA damage.

Slee EA, Lu X.

Toxicol Lett. 2003 Apr 4;139(2-3):81-7. Review.

PMID:
12628742
13.

The viral nucleocapsid protein of transmissible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6 and -7 during TGEV-induced apoptosis.

Eléouët JF, Slee EA, Saurini F, Castagné N, Poncet D, Garrido C, Solary E, Martin SJ.

J Virol. 2000 May;74(9):3975-83.

14.

Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis.

Slee EA, Adrain C, Martin SJ.

J Biol Chem. 2001 Mar 9;276(10):7320-6. Epub 2000 Oct 31.

16.

Serial killers: ordering caspase activation events in apoptosis.

Slee EA, Adrain C, Martin SJ.

Cell Death Differ. 1999 Nov;6(11):1067-74. Review.

17.

Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the WD-40 repeat region.

Adrain C, Slee EA, Harte MT, Martin SJ.

J Biol Chem. 1999 Jul 23;274(30):20855-60.

18.

Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells.

Chow SC, Slee EA, MacFarlane M, Cohen GM.

Exp Cell Res. 1999 Feb 1;246(2):491-500.

PMID:
9925765
19.

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ.

J Cell Biol. 1999 Jan 25;144(2):281-92.

20.

Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.

Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM.

Biochem J. 1996 Apr 1;315 ( Pt 1):21-4.

Supplemental Content

Support Center